UROTHELIAL BLADDER CARCINOMA
Clinical trials for UROTHELIAL BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for UROTHELIAL BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
MRNA cancer shots: new hope or hype?
Disease control OngoingThis early-stage trial tests two experimental mRNA therapies (mRNA-4106 and mRNA-4200) in 42 people with advanced solid tumors like melanoma, lung, or liver cancer. Some participants receive the mRNA therapy alone, others get it combined with the immunotherapy drug pembrolizumab.…
Matched conditions: UROTHELIAL BLADDER CARCINOMA
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug cocktail aims to wipe out bladder tumors before surgery
Disease control OngoingThis phase 2 trial is testing a combination of three drugs—sacituzumab govitecan, zimberelimab, and domvanalimab—given before and after surgery for muscle-invasive bladder cancer. The study includes 70 patients who cannot take standard cisplatin chemotherapy. The main goal is to …
Matched conditions: UROTHELIAL BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: Fundación para el Progreso de la Oncología en Cantabria • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC